News of Note—NIH Zika vaccine trial, VBI Vaccines and more

newspaper
(Pixabay)

Here is some other vaccine news of note for the week:

> The National Institutes of Health started a first-in-human study of a NIAID-developed live attenuated Zika virus vaccine candidate. Release

> VBI Vaccines appointed Christopher McNulty as its chief financial officer and head of business development. Release

INDUSTRY RESEARCH

Veeva 2019 Unified Clinical Operations Survey

Share your thoughts in this quick survey. The first 50 qualified respondents will receive a $5 Amazon gift card, and, in appreciation for your time, all qualified survey respondents will be entered in a drawing to win a $50 Amazon gift card.

> The Securities and Exchange Commission decided against further action after an investigation into possible securities law violations at Sinovac. Release

> BiondVax has moved manufacturing for its universal flu vaccine candidate to a new facility in the Jerusalem Bio Park. Release